GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Forward Dividend Yield %

Taiko Pharmaceutical Co (TSE:4574) Forward Dividend Yield % : 0.00% (As of May. 16, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Forward Dividend Yield %?

As of today (2025-05-16), the Forward Annual Dividend Yield of Taiko Pharmaceutical Co is 0.00%.

As of today (2025-05-16), the Trailing Annual Dividend Yield of Taiko Pharmaceutical Co is 0.00%.

TSE:4574's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.845
* Ranked among companies with meaningful Forward Dividend Yield % only.

Taiko Pharmaceutical Co's Dividends per Share for the three months ended in Jun. 2024 was 円0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Taiko Pharmaceutical Co was 81.70% per year. The lowest was 14.50% per year. And the median was 26.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Taiko Pharmaceutical Co's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiko Pharmaceutical Co's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's Forward Dividend Yield % falls into.


;
;

Taiko Pharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Taiko Pharmaceutical Co  (TSE:4574) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Taiko Pharmaceutical Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiko Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co Headlines

No Headlines